IMMUNE THROMBOCYTOPENIA IN MYELODYSPLASTIC SYNDROME WHICH WAS REFRACTORY TO ELTROMBOPAG WAS TREATED SUCCESSFULLY WITH RITUXIMAB

Pamuk, G.Maden, M.Uyanik, M.Alptekin, M.2024-06-122024-06-1220150145-21261873-5835https://doi.org/10.1016/S0145-2126(15)30196-Xhttps://hdl.handle.net/20.500.14551/2568713th International Symposium on Myelodysplastic Syndromes (MDS) -- APR 29-MAY 02, 2015 -- Washington, DC[Abstract Not Available]en10.1016/S0145-2126(15)30196-Xinfo:eu-repo/semantics/closedAccess[No Keywords]IMMUNE THROMBOCYTOPENIA IN MYELODYSPLASTIC SYNDROME WHICH WAS REFRACTORY TO ELTROMBOPAG WAS TREATED SUCCESSFULLY WITH RITUXIMABConference Object39S97S97Q3WOS:000373183500196